Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant
Condition(s):Allogeneic Stem Cell TransplantationLast Updated:March 20, 2014Terminated
Hide Studies Not Open or Pending
Condition(s):Allogeneic Stem Cell TransplantationLast Updated:March 20, 2014Terminated
Condition(s):Communication; Menopause; Hormone Replacement TherapyLast Updated:April 27, 2006Completed
Condition(s):CirrhosisLast Updated:August 29, 2017Completed
Condition(s):Menopause; Hormone Replacement TherapyLast Updated:April 7, 2015Completed
Condition(s):Hormone Refractory Prostate CancerLast Updated:December 15, 2011Completed
Condition(s):Breast CancerLast Updated:March 2, 2022Completed
Condition(s):Crohn’s DiseaseLast Updated:April 13, 2015Withdrawn
Condition(s):Growth Hormone Treatment; Growth DisordersLast Updated:September 14, 2023Recruiting
Condition(s):Phelan-McDermid Syndrome; Autism Spectrum Disorder (ASD)Last Updated:October 10, 2023Enrolling by invitation
Condition(s):Obesity; Growth HormoneLast Updated:August 23, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.